Solésence, Inc. named Contract Manufacturing Partner of the Year at the 2026 Cosmetics Business Innovation Awards for excellence in service and innovation.
Quiver AI Summary
Solésence, Inc., a leader in health care solutions for beauty and life sciences, has been awarded Contract Manufacturing Partner of the Year at the 2026 Cosmetics Business Innovation Awards, recognizing its excellence in client satisfaction, innovation, and service within the personal care supply chain. The awards, presented by HPCi Media, highlight significant advancements in the industry. Since 2022, Solésence has garnered 12 industry awards, underscoring its commitment to innovation and product development. With new technologies in skin health and plans for further advancements, Solésence aims to bridge the gap between beauty and wellness. CEO Kevin Cureton expressed gratitude for the recognition, emphasizing their role in helping brand partners meet consumer expectations while accelerating product development.
Potential Positives
- Solésence was named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards, highlighting its excellence in service, reliability, and innovation within the cosmetics industry.
- The company has earned 12 industry awards since 2022, demonstrating a strong track record of recognition for its innovative products and commitment to client satisfaction.
- Solésence's plans to expand its product offerings into active skin restoration signals a strategic move to leverage its technological advancements and potentially open new market opportunities.
- The CEO's comments reflect a strong relationship with brand partners, emphasizing the company's role in supporting their success with innovative, market-driven solutions.
Potential Negatives
- Company's dependence on a limited number of key customers could jeopardize financial stability if any customer cancels orders.
- Uncertain demand for the company's materials and products raises concerns about future revenue and growth prospects.
- Potential difficulties in complying with new government regulations could increase operational costs and impact financial viability.
FAQ
What award did Solésence, Inc. win in 2026?
Solésence, Inc. was named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards.
What factors contributed to Solésence's recognition?
Solésence was recognized for excellence in client satisfaction, innovation, reliability, service, scalability, and speed-to-market.
How many industry awards has Solésence won since 2022?
Solésence has earned 12 industry awards since 2022, including the 2026 Cosmetics & Toiletries Allē Awards.
What innovations does Solésence plan to launch?
Solésence plans to launch new technologies in skin health and healing, expanding into active skin restoration.
What is Solésence's mission?
Solésence's mission is to deliver joy through innovation, inclusivity, and the science of beautiful skin.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SLSN Insider Trading Activity
$SLSN insiders have traded $SLSN stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SLSN stock by insiders over the last 6 months:
- R JANET WHITMORE has made 2 purchases buying 2,500 shares for an estimated $4,786 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$SLSN Revenue
$SLSN had revenues of $13M in Q1 2026. This is a decrease of -11.41% from the same period in the prior year.
You can track SLSN financials on Quiver Quantitative's SLSN stock page.
You can access data on SLSN stock through the Quiver Quantitative API.
$SLSN Hedge Fund Activity
We have seen 25 institutional investors add shares of $SLSN stock to their portfolio, and 16 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY added 159,494 shares (+452.0%) to their portfolio in Q1 2026, for an estimated $151,296
- CITADEL ADVISORS LLC removed 50,810 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $48,198
- JANE STREET GROUP, LLC removed 39,056 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $37,048
- KINGSVIEW WEALTH MANAGEMENT, LLC removed 30,770 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $49,078
- BARCLAYS PLC removed 25,162 shares (-51.6%) from their portfolio in Q1 2026, for an estimated $23,868
- MODERN WEALTH MANAGEMENT, LLC removed 24,269 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $23,021
- NORTHERN TRUST CORP added 18,143 shares (+15.2%) to their portfolio in Q1 2026, for an estimated $17,210
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
Global Award Recognizes Excellence in Service, Reliability, and Innovation
ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc . (Nasdaq: SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, has been named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards.
Presented by HPCi Media, the Cosmetics Business Innovation Awards recognize and celebrate the most important innovations driving progress across the global cosmetics and personal care supply chain. The B2B-focused awards program spotlights the very best in ingredients, packaging, contract manufacturing, technology, testing, regulatory and compliance.
As Contract Manufacturing Partner of the Year, Solésence was recognized for excellence in client satisfaction, innovation, product development, reliability, scalability, service, and speed-to-market. Winners were announced by the judges on June 11 via a broadcast recording .
Solésence’s excellence in innovation and service has earned 12 industry awards since 2022, including, most recently, the 2026 Cosmetics & Toiletries Allē Awards across three categories. With the launch of new technologies in the skin health and healing space and plans to expand its platform beyond environmental protection into active skin restoration, Solésence is poised to bring the same ingredient-led, patent-backed innovation that transformed SPF aesthetics into new frontiers that bridge beauty, health, and wellness.
“We are honored to receive this award, which reflects the strength of our product innovations as well as how we bring them to market and support the success of our brand partners,” commented Kevin Cureton, President and Chief Executive Officer of Solésence. “As brands face increasing pressure to accelerate product development timelines while meeting evolving consumer expectations, we are grateful for the trust our brand partners place in us to deliver ingredient-led, patent-backed innovations that expand what’s possible in environmental protection and skin health across categories. This year, we’ve deepened that support through our unique, technology-driven products and tailored marketing activations that help our brand partners succeed.”
About Solésence, Inc.
Solésence, Inc. (Nasdaq: SLSN), is a leader in scientifically-driven health care solutions across beauty and life science categories. With a mission to deliver joy through innovation, inclusivity and the science of beautiful skin, we have redefined mineral-based sun protection by maximizing transparency, effectiveness, aesthetics, and wearability — empowering individuals to embrace beauty on their own terms. Combining best-in-class skin health solutions with the celebration of self-care, we allow brands to deliver unique product claims and attributes by seamlessly integrating protection, prevention, and treatment technologies into daily use products. Learn more at solesence.com .
Forward-Looking Statements
This press release contains words such as “expects,” “shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance, and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s engineered materials, ingredients, and fully formulated products; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company’s Form 10-K filed March 31, 2026. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties, or other contingencies.
Media Contact:
[email protected]
Investor Relations Contact:
[email protected]